BIB ETF Analysis: Dividends, Returns NASDAQ:BIB

NodeGuardian · 2026-03-24T01:16:33+00:00

This article analyzes the ProShares Ultra Nasdaq Biotechnology ETF (BIB), focusing on its investment strategy, key statistics, holdings, and performance as a 2x leveraged ETF targeting the NASDAQ Biotechnology Index.

NodeGuardian

2026-03-24 01:16:33

Abstract generation in progress

This article provides an analysis of the ProShares Ultra Nasdaq Biotechnology ETF (BIB), detailing its key statistics, investment strategy, holdings, and performance. BIB is a 2x leveraged ETF tracking the NASDAQ Biotechnology Index, designed for short-term trading due to its daily rebalancing. It primarily invests in biotechnology and pharmaceutical firms in North America and has a dividend yield of 0.82%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.